These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34095346)

  • 1. Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells.
    Nguyen TNT; Sha S; Hong MS; Maloney AJ; Barone PW; Neufeld C; Wolfrum J; Springs SL; Sinskey AJ; Braatz RD
    Mol Ther Methods Clin Dev; 2021 Jun; 21():642-655. PubMed ID: 34095346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidose transient transfection of human embryonic kidney 293 cells modulates recombinant adeno-associated virus2/5 Rep protein expression and influences the enrichment fraction of filled capsids.
    Srinivasan P; Canova CT; Sha S; Nguyen TNT; Joseph J; Sangerman J; Maloney AJ; Katsikis G; Ou RW; Hong MS; Ng J; Yuan A; Antov D; Song S; Chen W; Neufeld C; Wolfrum JM; Barone PW; Sinskey AJ; Springs SL; Braatz RD
    Biotechnol Bioeng; 2024 Dec; 121(12):3694-3714. PubMed ID: 39176568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.
    Destro F; Joseph J; Srinivasan P; Kanter JM; Neufeld C; Wolfrum JM; Barone PW; Springs SL; Sinskey AJ; Cecchini S; Kotin RM; Braatz RD
    Mol Ther Methods Clin Dev; 2023 Sep; 30():122-146. PubMed ID: 37746245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus.
    Tang Q; Keeler AM; Zhang S; Su Q; Lyu Z; Cheng Y; Gao G; Flotte TR
    Biores Open Access; 2020; 9(1):219-228. PubMed ID: 33117614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
    Wang Y; Fu Q; Park SY; Lee YS; Park SY; Lee DY; Yoon S
    Biotechnol Adv; 2024; 71():108322. PubMed ID: 38336188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the production of adeno-associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design-of-experiment optimization of triple plasmid ratio.
    Park S; Shin S; Lee H; Jang JH; Lee GM
    Biotechnol J; 2024 Mar; 19(3):e2300667. PubMed ID: 38479987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ER protein processing gene expression increases rAAV yield and full capsid ratio in HEK293 cells.
    Fu Q; Wang Y; Qin J; Xie D; McNally D; Yoon S
    Appl Microbiol Biotechnol; 2024 Sep; 108(1):459. PubMed ID: 39230729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
    Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
    J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection.
    Liu H; Zhang Y; Yip M; Ren L; Liang J; Chen X; Liu N; Du A; Wang J; Chang H; Oh H; Zhou C; Xing R; Xu M; Guo P; Gessler D; Xie J; Tai PWL; Gao G; Wang D
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101230. PubMed ID: 38558570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics kinetic analysis of recombinant adeno-associated virus production by plasmid transfection of HEK293 cells.
    Lu M; Lee Z; Hu WS
    Biotechnol Prog; 2024; 40(2):e3428. PubMed ID: 38289617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes.
    van Lieshout LP; Rubin M; Costa-Grant K; Ota S; Golebiowski D; Panico T; Wiberg E; Szymczak K; Gilmore R; Stanvick M; Burnham B; Gagnon J; Iwuchukwu I; Yang G; Ghazi I; Meola A; Dickerson R; Thiers T; Mustich L; Hayes A; Rivas I; Lotterhand J; Avila N; McGivney J; Yin J; Kelly T
    Mol Ther Methods Clin Dev; 2023 Jun; 29():426-436. PubMed ID: 37273900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the production of recombinant adeno-associated virus in synthetic cell lines through systematic characterization.
    Lu M; Lee Z; Lin YC; Irfanullah I; Cai W; Hu WS
    Biotechnol Bioeng; 2024 Jan; 121(1):341-354. PubMed ID: 37749931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity.
    Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS
    Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.